Free shipping on all orders over $ 500

Pioglitazone HCl

Cat. No. M5878

All AbMole products are for research use only, cannot be used for human consumption.

Pioglitazone HCl Structure
Synonym:

AD-4833, U-72107E

Size Price Availability Quantity
100mg USD 30 In stock
500mg USD 60 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pioglitazone HCl is a selective peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist, used to treat diabetes.

Product Citations
Chemical Information
Molecular Weight 392.9
Formula C19H20N2O3S.HCl
CAS Number 112529-15-4
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage 2-8°C, dry, sealed
References

[1] Heneka MT, et al. Ann Neurol. Effect of pioglitazone medication on the incidence of dementia.

Related PPAR Products
WY 14643 (Pirinixic Acid)

WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist.

Rosiglitazone

Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50=60 nM, Kd=40 nM). Rosiglitazone is an TRPC5 activator (EC50=30 μM) and TRPM3 inhibitor.

GSK 3787

GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).

Rosiglitazone maleate

Rosiglitazone maleate (Avandia) is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM.

Ciprofibrate

Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pioglitazone HCl, AD-4833, U-72107E supplier, PPAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.